Fig. 1From: Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathwayExpression of HIG2 in HCC tissues and cells. a Overall survival of HCC patients with different levels of HIG2 expression. b Disease-free survival of HCC patients with different levels of HIG2 expression. c HIG2 mRNA expression in HCC tissues in comparison with tumor-adjacent tissues. *P < 0.05. d HIG2 mRNA expression in HCC tissues from patients with or without lymph node metastasis in comparison to tumor-adjacent tissues. *P < 0.05. e HIG2 mRNA expression in HCC tissues from patients with TNM Stage I/II or III/IV disease in comparison to tumor-adjacent tissues. *P < 0.05. f Immunohistochemical analysis of HIG2 expression in HCC tissues and tumor-adjacent tissues. g High incidence of HIG2 expression in HCC tissues in comparison to tumor-adjacent tissues. *P < 0.05. h Expression of HIG2 mRNA in HepG2 and SMMC-7721 cells in comparison to tumor-adjacent tissues. *P < 0.05Back to article page